We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Stem Cell Defects May Cause Breast Cancer

By Biotechdaily staff writers
Posted on 28 Oct 2005
The onset of breast cancer may be caused by defects in somatic adult stem cell niches that exist long before a tumor develops, according to researchers at the Lombardi Comprehensive Cancer Center of Georgetown University (Washington, DC, USA).

The research built on prior findings that demonstrated the existence of five different types of cells in normal breast cancer tissue. More...
Two are stem cell-like and give rise to the other three. For the current study, all cell types were identified at low magnification, allowing more cells to be counted. Not only did each cell population have a different size in normal breast tissue but the cells are arranged in particular relationships to each other. These form repeating units called stem cell niches and provide microenvironments that house the adult stem cells and their daughter cells.

In mice that expressed excess amounts of either of the cancer-producing proteins, the size of the cell populations changed in relation to each other. The order of the cell arrangements was disrupted in the stem cell niches of mice with breast cancer, showing that each cell population may play a different role in the development of breast cancer and that the environment in which a cell grows can influence its chance of becoming cancerous.

"The results also show how complicated cancer is as a disease,” said lead author Gloria Chepko, Ph.D., a postdoctoral fellow at the Lombardi Comprehensive Cancer Center. "Although it's not something that will be solved easily or quickly, our study reveals important information on the genesis of breast cancer in the body.” The findings were reported in the October 2005 issue of Tissue and Cell.




Related Links:
Lombardi Comprehensive Cancer Center

Platinum Member
ADAMTS-13 Protease Activity Test
ATS-13 Activity Assay
Verification Panels for Assay Development & QC
Seroconversion Panels
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
Melanoma Panel
UltraSEEK Melanoma Panel
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.